DRI expects to launch Fund III later this year
The Toronto-based drug royalty-focused firm closed its second fund on $701m last year and has been investing at a quick pace.
5 January 2013•2 mins read
The Toronto-based drug royalty-focused firm closed its second fund on $701m last year and has been investing at a quick pace.
